ALLMedicine™ Hypertriglyceridemia Center
Research & Reviews 1,530 results
https://doi.org/10.1016/j.clml.2021.07.009
Clinical Lymphoma, Myeloma & Leukemia; Schmiegelow K, Rank CU et. al.
Sep 14th, 2021 - A wider use of L-asparaginase in the treatment of children with acute lymphoblastic leukemia has improved cure rates during recent decades and hence led to introduction of pediatric-inspired treatment protocols for adolescents and young adults. In...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412820
Vascular Health and Risk Management; Charoensri S, Turnsaket S et. al.
Sep 14th, 2021 - Fasting hypertriglyceridemia commonly associates with insulin resistance and is frequently prevalent in type 2 diabetes mellitus (DM). However, hypertriglyceridemia has not been investigated as an independent predictor of incidence of DM, especial...
https://doi.org/10.1007/s11883-021-00962-z 10.1161/CIRCRESAHA.115.306249 10.1016/j.jacc.2018.11.002 10.1093/eurheartj/ehz455 10.1210/jc.2011-3213 10.5339/gcsp.2015.33 10.1210/js.2019-00129 10.1001/archinte.161.3.397 10.1210/jc.2011-1159 10.1210/jc.2014-1878 10.1002/hep.23593 10.1172/JCI134165 10.1056/NEJMoa0907295 10.1038/nrneph.2017.155 10.1038/nm.3396 10.1172/JCI107017 10.1016/j.mcna.2012.01.012 10.1210/jcem.87.4.8378 10.1159/000314213 10.1677/JOE-08-0054 10.1016/0026-0495(75)90129-8 10.1016/0026-0495(80)90112-2 10.1152/ajpendo.1986.250.3.E269 10.1016/j.numecd.2007.01.014 10.1016/j.atherosclerosis.2014.05.443 10.1210/jc.2007-1972 10.1111/j.1365-2265.1982.tb00731.x 10.7326/0003-4819-111-4-288 10.1007/s11102-008-0097-3 10.1210/jc.2002-021137 10.1016/j.steroids.2011.12.002 10.1159/000242614 10.1210/jcem-64-4-704 10.2337/dc07-s202 10.1210/jc.2012-1250 10.1016/j.jacl.2020.05.082 10.1177/1753495X15594082 10.1007/s11892-018-1008-2 10.1016/S0025-7125(16)30179-1 10.1016/0026-0495(75)90078-5 10.1056/NEJM199110243251702 10.1016/j.jacl.2020.04.011 10.1016/j.atherosclerosis.2018.06.814 10.1097/MED.0000000000000316 10.3109/10408363.2013.870526 10.1001/jamacardio.2019.3780 10.4158/EP-2018-0157 10.1161/ATVBAHA.119.313401 10.1016/S0022-2275(20)38008-1 10.1002/iub.2073 10.1016/j.jacc.2012.08.1026 10.1038/ng.2795 10.1186/s12933-019-0916-z 10.1001/2013.jamainternmed.477 10.1016/j.atherosclerosissup.2010.03.004 10.1503/cmaj.060963 10.1016/j.ejim.2014.08.008 10.1016/j.jacl.2020.11.010 10.4103/1947-2714.168657 10.1080/14779072.2017.1311786 10.1161/CIR.0b013e3182160726 10.1001/archinternmed.2008.599 10.1016/j.jacl.2013.04.001 10.1016/j.jacl.2015.09.002 10.1093/ajcn/77.5.1146 10.1161/CIRCULATIONAHA.109.192627 10.1016/j.jacl.2019.08.003 10.1016/j.jacl.2018.04.010 10.1016/j.jacl.2019.10.014 10.1056/NEJMoa1812792 10.1001/jama.2020.22258 10.1161/01.CIR.98.19.2088 10.1007/s11883-016-0571-8 10.1056/NEJM198711123172001 10.1056/NEJM199908053410604 10.1016/S0140-6736(14)61177-6 10.1016/j.atherosclerosis.2017.03.032 10.1016/j.ahj.2018.09.011 10.1007/s40265-014-0339-9 10.1016/j.atherosclerosis.2014.05.007 10.1056/NEJMoa1715944 10.1093/eurheartj/ehaa689 10.1161/CIRCULATIONAHA.118.039107
Current Atherosclerosis Reports; Hernandez P, Passi N et. al.
Sep 14th, 2021 - Hypertriglyceridemia (HTG) is common and is a significant contributor to atherosclerosis and pancreatitis risk. Specific HTG treatments have had variable success in reducing atherosclerosis risk. Novel therapies for severe HTG treatment and pancre...
https://doi.org/10.1007/s00394-021-02674-1 10.14310/horm.2002.1697 10.1007/s12020-012-9867-9 10.1111/j.1467-789X.2009.00707.x 10.1016/j.diabres.2007.05.004 10.1136/bmj.i5953 10.2337/dc19-S003 10.1039/c0np00018c 10.2903/j.efsa.2011.2207 10.1016/j.foodchem.2011.04.053 10.1017/S0007114513001682 10.2337/dc16-0351 10.1017/S0007114516001938 10.3945/ajcn.2009.28191 10.3390/nu7125536 10.1094/CCHEM-86-6-0601 10.1007/s11947-018-2065-x 10.1016/j.foodchem.2013.05.078 10.1016/j.foodchem.2016.08.010 10.1021/acs.jafc.8b01532 10.1016/j.foodchem.2014.03.121 10.1016/S0308-8146(00)00304-6 10.1007/s11130-012-0330-0 10.1016/j.foodchem.2017.01.108 10.1002/ptr.5255 10.2337/dc18-S002 10.1093/epirev/mxt007 10.1615/IntJMedMushrooms.2018028980 10.1007/s40093-019-00317-4 10.1007/978-3-662-55722-8 10.2337/diab.43.4.535 10.1210/jc.2011-0266 10.1038/sj.ijo.0801083 10.1016/S0899-9007(00)00553-0 10.3390/nu8090524 10.1079/NRR2005100 10.1093/ajcn/nqz285 10.3390/molecules24152740 10.3390/foods9020160 10.1042/bse0420089 10.1016/j.cmet.2017.03.008 10.1007/s00394-019-02162-7 10.1038/ejcn.2016.248 10.1139/H09-119 10.1038/ijo.2015.172 10.1079/NRR200371 10.1186/s12937-017-0233-x
European Journal of Nutrition; Dicks L, Jakobs L et. al.
Sep 11th, 2021 - Impaired glucose tolerance (IGT) is a pathophysiological condition characterized by insulin resistance with known metabolic consequences such as postprandial hyperglycemia and hypertriglyceridemia. We hypothesized that fortifying a meal with mushr...
https://doi.org/10.5414/CP204091
International Journal of Clinical Pharmacology and Therap... Saito Y, Takekuma Y et. al.
Sep 11th, 2021 - We previously reported a case where S-1, containing tegafur, gimeracil, and oteracil potassium, induced severe hypertriglyceridemia. After the case, we regularly monitored serum lipid levels and surprisingly observed an additional 4 cases within 1...
Guidelines 1 results
https://doi.org/10.1016/j.jacc.2021.06.011
Journal of the American College of Cardiology; Virani SS, Morris PB et. al.
Aug 2nd, 2021 - 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee.|2021|Virani SS,Morris PB,Agarwa...
Drugs 592 results see all →
Clinicaltrials.gov 3 results
https://clinicaltrials.gov/ct2/show/NCT04365400
Sep 8th, 2021 - To assess the efficacy and safety of orally administered Epeleuton capsules versus placebo, in the treatment of adult patients with hypertriglyceridemia and type 2 diabetes
https://clinicaltrials.gov/ct2/show/NCT04361422
Sep 23rd, 2020 - The study is a randomized interventional comparative Phase III trial. The duration of the trial for each subject is expected to be 3 months. The duration for each individual subject includes one-month study treatment and 3 months follow-up time. R...
https://clinicaltrials.gov/ct2/show/NCT01301794
Feb 25th, 2013 - This study will investigate changes in lipid and other metabolic parameters as well as the ability of isolated lipoproteins to activate PPARs in the presence or absence of lipoprotein lipase in a cohort of normal healthy individuals with modest hy...
News 132 results
https://www.onclive.com/view/bipolar-androgen-therapy-demonstrates-comparable-efficacy-with-enzalutamide-in-mcrpc
Mar 11th, 2021 - Bipolar androgen therapy demonstrated clinically meaningful activity and a good safety profile compared with enzalutamide (Xtandi) in asymptomatic men with metastatic castration-resistant prostate cancer (mCRPC) who progressed on abiraterone aceta...
https://www.onclive.com/view/ma27-study-finds-exemestane-and-anastrozole-comparable
Dec 5th, 2020 - Exemestane (Aromasin) was no better than anastrozole (Arimidex) at reducing cancer recurrence in postmenopausal women with hormone receptor-positive primary breast cancer, according to final data from the NCIC CTG MA.27 trial presented at the San ...
https://www.medscape.com/viewarticle/939205
Oct 15th, 2020 - Calculating the ratio between serum triglyceride and apolipoprotein B levels may help rule out patients with hypertriglyceridemia who are at low risk of developing hypertriglyceridemic pancreatitis (HTGP), and so better guide management, suggests ...
https://www.staging.medscape.com/viewarticle/939205
Oct 15th, 2020 - Calculating the ratio between serum triglyceride and apolipoprotein B levels may help rule out patients with hypertriglyceridemia who are at low risk of developing hypertriglyceridemic pancreatitis (HTGP), and so better guide management, suggests ...
https://reference.staging.medscape.com/viewarticle/932048_2
Jun 16th, 2020 - Figure 1. Hemophagocytosis in the bone marrow. The diagnosis of HLH is based on clinical criteria. Diagnostic criteria that were developed by the Histiocyte Society for HLH (HLH-2004 criteria) are the most commonly used. They include: Fever: ≥ 7 d...
